Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00401206 · ClinicalTrials.gov registry record · NA

Use of Dexmedetomidine for Sedation During Flexible Bronchoscopy in Patients With COPD: A Descriptive Study

A NA study of COPD and Sedation, sponsored by The Cooper Health System.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT00401206 is a NA study of COPD and Sedation that has completed, run by The Cooper Health System. The registered enrollment target is 12 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00401206, a NA study of COPD and Sedation, has completed, sponsored by The Cooper Health System.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

To determine safety and effectiveness of dexmedetomidine when administered for conscious sedation during flexible bronchoscopy (FB) in patients with Chronic Obstructive pulmonary Disease (COPD).

Interventions

  • DRUG dexmedetomidine

Study Locations (1)

New Jersey

  • Cooper University Hospital - Camden

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2006-11
Est. Completion 2007-06
Phase NA

Sponsor

The Cooper Health System

39 total trials

What the Registry Record Tells You About NCT00401206

The ClinicalTrials.gov registry entry for NCT00401206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower). The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which dexmedetomidine is the first listed.

NCT00401206 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00401206 about?

NCT00401206 is a clinical study titled "Use of Dexmedetomidine for Sedation During Flexible Bronchoscopy in Patients With COPD: A Descriptive Study". To determine safety and effectiveness of dexmedetomidine when administered for conscious sedation during flexible bronchoscopy (FB) in patients with Chronic Obstructive pulmonary Disease (COPD).

What is the current status of trial NCT00401206?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2006-11. Estimated completion is 2007-06.

What conditions does trial NCT00401206 study?

This clinical trial studies the following conditions: COPD, Sedation, Flexible Bronchoscopy.

What interventions are being tested in trial NCT00401206?

The interventions under investigation include: dexmedetomidine (DRUG).

Who is sponsoring clinical trial NCT00401206?

This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00401206 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.